A top-level collaboration to produce high-grade
pharmaceutical-quality cannabis for therapeutic use
pharmaceutical-quality cannabis for therapeutic use
Premium
Genetic Capital
More than 35 years
of combined experience
Experts in agronomic management and innovation
and cannabis cultivation
Continuous improvement
through ongoing R&D&I
Pharmaceutical quality production
under the highest standards
Developing innovative, reliable and high-quality cannabis therapeutic solutions for the treatment of diseases and health conditions that have not found relief or effective treatment yet, by adding the experience and assets of our founding partners and combining the skills and knowledge of our team.
Our Purpose
We seek to incorporate new tools into the therapeutic arsenal of the healthcare systems, and assist professionals, suppliers and healthcare administrations, as well as the pharmaceutical industry, to improve health outcomes and the quality of life of their patients.
Our Purpose
NovArkanta is the union between medcann Europe, a subsidiary of the medcann Pharma Inc. Business Group, a global supplier of cannabis genetics, legal and traceable origin; and Dast, a spin-off of a renowned Spanish agricultural sector company with extensive experience in plant varieties crops with high added value.
- Subsidiary of the medcann Pharma Inc. Business Group, a worldwide provider of cannabis genetics.
- Extensive, premium quality genetic capital.
- Registered and traceable genetics.
- Experts in genetic improvement, plant variety hybridization and characterization. Ongoing R&D programs and large-scale collaborative projects with multiple actors.
- Authorization of the Spanish Agency of Medicines and Health Products (AEMPS) as supplier of legal source cannabis genetics, for medical and scientific purposes.
- More than 30 years of experience of a world-class management, technical-scientific and agricultural team.
- Founding partners with extensive experience in the provision of comprehensive management and development services of agricultural assets, featuring optimal performance levels.
- Technical knowledge and agronomic management specialized in plant varieties crops with high added value, with state-of-the-art technology and innovative capacity.
- Ecological production and continuous process improvement.
- Sustainability based on economic, environmental and social profitability.
The Team
We add the cumulative experience and assets of our founding partners and combine our team’s skills and knowledge to be the best at what we do, and serve the therapeutic cannabis industry and the healthcare sector in a distinctive way.
-
Carlos Guzmán
-
Co-CEO & Co-Founder
-
Ignacio García-Toledo
-
Co-CEO & Co-Founder
-
Ana Canalejo
-
Commercial Director
-
Pelayo de la Fuente
-
Technical & Operations Director